Table 1.
Case | Control | ||
---|---|---|---|
Factor | n = 30 | n = 108 | p value |
Sex, n (%) | |||
Female | 14 (47%) | 52 (48%) | Matching factor |
Male | 16 (53%) | 56 (52%) | |
Age, n (%) | |||
Less that 37 years | 14 (47%) | 56 (52%) | Matching factor |
Older than 37 years | 16 (53%) | 52 (48%) | |
CD4 count class, n (%) | |||
Less than 200 | 16 (53%) | 60 (56%) | |
200–500 | 8 (27%) | 24(22%) | Matching factor |
Greater than 500 | 6 (20%) | 24 (22%) | |
Median CD4 count at diagnosis, (IQR) | 131 (40–468) | 177 (109–491) | 0.09 |
On ART at time of diagnosis, n (%) | 7 (23%) | 21 (19%) | 0.61 |
Comparison of K8.1 results between cases and controls | |||
Median K8.1 titre at diagnosis (IQR) | 2640 (660–10,240) | 40 (0–80) | <0.0001 |
Median K8.1 titre of all samples (IQR) | 320 (80–2,560) | 40 (0–80) | <0.0001 |
Comparison of LANA results between cases and controls | |||
Median LANA titre at diagnosis (IQR) | 3200 (200–102400) | 800 (0–25,600) | <0.0001 |
Median LANA titre of all samples (IQR) | 3200 (100–102,400) | 800 (0–12,800) | <0.0001 |
p value calculated using Ranksum test, unless otherwise stated
χ2 test